Lipid Management/ZC-SLM/Probiotics Premix/500B
Shelf life: 24 months
Storage conditions: Stored at -18℃ or below
Main Strains
Health Benefits

√ Improve blood glucose metabolism and assist in the treatment of type 2 diabetes
√ Improve lipid metabolism
√ Improve high density and low density cholesterol content
√ Improve atherosclerosis
√ Help improve hypertension
Three-dimensional interventions (body fat, visceral fat, lipids)

The advantages of probiotics in fat-lowering

Enhancing levels of GLP-1 and PYY, upregulating the glucagon gene, and bidirectionally regulating blood glucose.

Lactiplantibacillus plantarum F3-2 showed significant improvement in body fat
NC:control group HFD:fatty liver group OR:orlistat group F3-2:probiotic group

The data presented in the figure indicates that after a period of feeding, the body weight of mice in the high-fat diet group significantly increased compared to the control group. In contrast, the weight gain observed in mice subjected to Lactiplantibacillus plantarum F3-2 intervention was markedly lower than that of the high-fat diet group. This clearly demonstrates the positive regulatory effect of Lactiplantibacillus plantarum F3-2 on obesity induced by a high-fat diet.
Reference: Lactiplantibacillus plantarum F3-2 and mannooligosaccharides alleviated the obesity of mice through up-regulating SCFAs and inhibiting PPARγ Experimental Study on Lactiplantibacillus plantarum F3-2.
Reduce the size of fat cells and relieve excessive fat accumulation Experimental Study on Lactiplantibacillus plantarum F3-2
NC: Control group HFD: High-fat diet group OR: Orlistat group Plant F3-2: Probiotic group

Conclusion:
F3-2, repair s fatt y l i ver and restores hepatic lipid-processing function, similar to the positive drug orlistat.
Reference: A strain of Lactiplantibacillus plantarum F3-2 and its application
H-87 inhibits the enlargement of adipocytes and reduces body fat
NLow-fat diet feeding group (LFD), high-fat diet feeding group (HFD), probiotic + high fat diet group (H-87)

Reference: Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice.
H-87 reduces liver lipogenesis

Reference: Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL/6J mice.
Experimental Study on Lactiplantibacillus plantarum H-87
Low-fat diet fed group (LFD), high-fat diet fed group (HFD), probiotics + high-fat diet group (H-87)
A high-fat diet significantly increases liver weight and triglyceride (TG) levels, while H-87 supplementation can markedly reduce liver weight, liver TG, and cholesterol (CHOL) in mice subjected to a high-fat diet, thereby decreasing hepatic fat accumulation.
Lower total cholesterol and triglyceride levels
Experimental Study on Lacticaseibacillus paracasei G1
Normal control group (N); Diabetic control group (D); Metformin treated group (M); Lacticaseibacillus G15 treated group (G); Lacticaseibacillus Q14 treated group (Q)

Experimental conclusion:
G15 reduces serum triglycerides andtotal cholesterol levels, modulates bloodlipids, and stabilizes body lipidmetabolism.
